Get Brochure

Regulatory Medical Writing Services

Medical writing is a fundamental need in the pharmaceutical and biotechnological industries, essential throughout the lifecycle of a product—from clinical development and regulatory submissions to safety assessments and post-market surveillance. DDReg’s specialized medical writing services address the multifaceted challenges associated with regulatory and safety documentation, including navigating ever-evolving regulations, analyzing complex data, and ensuring effective risk communication.

Regulatory and Safety Writing Solutions

Our regulatory writing services are designed to meet the highest standards of quality and compliance. We specialize in the creation of crucial documents such as:

  • Clinical and nonclinical sections of the eCTD (Modules 2.4 to 2.7)
  • Product labels (SPC/PIL/PIs)
  • Biowaiver justifications
  • Product reviews
  • Pharmacoeconomic write-ups
  • Clinical study reports
  • Study protocols
  • Investigator’s brochures
  • Annual safety reports
  • Development Safety Update Reports (DSURs)
    • Aggregate Reports
    • Periodic Safety Update Reports (PSURs)
    • Periodic Benefit-Risk Evaluation Reports (PBRERs)
    • Periodic Adverse Drug Experience Reports (PADERs)

These documents are essential for regulatory submissions and require a deep understanding of regulatory guidelines, extensive experience, and an in-depth knowledge of the dynamic regulatory landscape.

Why Choose DDReg for Safety and Regulatory Writing Services?


Our Expertise and Excellence in Medical Writing

With over 14 years of experience, DDReg has established itself as a premier provider of regulatory medical writing services globally. Our team consists of highly qualified medical and scientific writing professionals dedicated to delivering documents of the highest quality and scientific rigor. Our success is built on:

  • Extensive industry and subject-matter expertise
  • Experience with over 120 regulatory agencies
  • Robust processes governed by Standard Operating Procedures (SOPs), checklists, and thorough reviews
  • Compliance with international standards and guidelines

Client-Focused Approach

Our medical writing consultant team integrates client-specific processes and templates to produce precise and accurate documents. We work closely with the Regulatory Affairs and Pharmacovigilance departments to ensure timely project completion and optimal time management. Our capabilities include:

  • Developing and reviewing documents essential for clinical development, regulatory submissions, drug safety, and pharmacovigilance
  • Gathering relevant information from diverse sources such as scientific literature and safety data
  • Drafting, compiling, and rigorously reviewing a wide array of documents

Global Reach

DDReg has a proven track record of collaborating with leading global organizations, including pharmaceutical companies, Contract Research Organizations (CROs), and Biotechnology firms. We support submissions to stringent regulatory authorities such as the US FDA, EMA, UK MHRA, PMDA, Health Canada, and authorities in emerging markets (LatAM, CIS, MENA, GCC, ASEAN, ANZ). Our team undergoes thorough scientific, editorial, and quality control reviews to ensure all documents meet the highest standards.

DDReg offers a diverse range of medical writing solutions throughout all stages of the product lifecycle:

Clinical Development Plan & Documentation:

Diversity Plan

Preparation and/or review of IB, Safety Narratives, Informed consent documents, safety summaries, and clinical overviews

Medical Rationale e.g.: FDCs, Fast track designation request, etc.

Orphan Drug Designation

Preparation and submission of Paediatric Investigation Plan

Pre-submission/ Agency Meeting support (e.g.: FDA meetings(Type A, Type B & Type C), UK MHRA Scientific meetings, PMDA meetings, etc.) - Pre-meeting packages (PMPs)/briefing packages

Preparation & review of posters, Abstracts

Quality and regulatory review of clinical study reports for global submission

Regulatory due diligence of early phase, Phase IIa/IIb, Phase III & Bioequivalence clinical protocols (e.g. FDA requirements & guidance documents)

Regulatory Filing and Submission:

Authoring, compilation as well as a review of Clinical and Non-Clinical sections (i.e., Section 2.4 to 2.7 & M4 & M5) of NDA & ANDA for global submissions

Authoring, review & update of SPC, PIL, CCDS, SPL, PI

Bio Waiver Justification, “Well Established Use” justifications for EU

Conducts critical literature review

Development/Review of Risk Management Plan(RMP)

Preparation & review of clinical & Non-clinical modules of BLA

Pharmacoeconomic write-ups

Regulatory Query response preparation and submission

Support integrated summary reports on Efficacy and safety

Support Risk Evaluation & Mitigation Strategy (REMS)

Post Approval & Life Cycle Management:

Authoring and compilation of aggregate safety reports (PADERs, PBRERs & PSURs)

Authoring, review & compilation of post-life-cycle management (Label updates, Clinical and non-clinical documentation, etc.)

Advertisement storyboard review service

Clinical Trial Transparency and Disclosure

Claims development for CHC & Cosmetics

Development of RMPs, RMMs, ARMMs

Patient narratives for PASS studies (ICH-E3 Section 14.3)

Pregnancy Prevention Program (PPP)

Review of protocols & CSRs for Phase IV studies.

Scientific Communication: Manuscript, Product Monographs, slide decks, posters & abstract, etc.

Website content

Customized Services to Meet Your Needs

Our medical writing consultants function as an extension of your team, adaptable to your unique needs. We specialize in transforming complex data into precise, evidence-based narratives that detail the clinical profile of a drug in terms of treatment efficacy and patient safety.

How can we help you?
Call us on:+1 (302) 601-2755
Contact our experts today !
Related Articles
loader